CLINICAL_TRIALS
trial_result
· 2026-04-21
Clinical Trial Update: Phase ll Study of HEC585 in Patients With IPF [Phase 2]
Summary
Phase 2 clinical trial update for HEC585 in idiopathic pulmonary fibrosis; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING